Your browser doesn't support javascript.
loading
Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?
Alffenaar, J-W C; Marais, B J; Thomas, T A.
Affiliation
  • Alffenaar JC; Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW.
  • Marais BJ; Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW, Children´s Hospital Westmead, Sydney, NSW, Australia.
  • Thomas TA; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA.
Int J Tuberc Lung Dis ; 25(11): 879-880, 2021 11 01.
Article in En | MEDLINE | ID: mdl-34686227
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Isoniazid Limits: Child / Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Isoniazid Limits: Child / Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2021 Document type: Article